Related Experiment Video
Updated: Feb 7, 2026

Assessment of Cerebral Lateralization in Children using Functional Transcranial Doppler Ultrasound fTCD
Published on: September 27, 2010
Cerebral Vasoreactivity in Children with Sickle Cell Disease: A Transcranial Doppler Study
Rejane de Souza Macedo-Campos1, Samuel Ademola Adegoke2, Maria Stella Figueiredo3
1Disciplina de Neurologia Clínica, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.
Insights
Children with sickle cell disease (SCD) show impaired cerebral vasoreactivity. This study found lower breath-holding index (BHI) values in pediatric SCD patients, indicating reduced cerebrovascular autoregulation capacity.
Area of Science:
- Pediatric Neurology
- Vascular Biology
- Hematology
Background:
- Reduced vasodilatory capacity and cerebrovascular reserve are observed in adults with sickle cell disease (SCD), potentially contributing to stroke.
- This study investigates whether children with SCD also exhibit impaired cerebral vasoreactivity compared to healthy controls.
Purpose of the Study:
- To determine the frequency of impaired cerebral vasoreactivity in children with SCD.
- To compare cerebral vasoreactivity between children with SCD and healthy controls.
Main Methods:
- Transcranial Doppler (TCD) ultrasonography with a breath-holding maneuver was used in 42 SCD patients (ages 10-18) and 20 healthy controls.
- The Breath-holding Index (BHI) was calculated by correlating the percentage increase in mean flow velocity during breath-holding with the breath-hold duration.
- An abnormal BHI was defined as a value less than 0.69.
Main Results:
- Patients with SCD exhibited significantly higher blood flow velocities in all evaluated arteries compared to controls (P < .001).
- SCD patients had significantly lower BHI values on both the left (1.27 ± 0.65 vs. 1.74 ± 0.15) and right (1.16 ± 0.45 vs. 1.61 ± 0.11) sides (P = .013 and P = .002, respectively).
- Abnormal BHI values were found in 19% of SCD patients, compared to none of the controls (P = .036).
Conclusions:
- Children with SCD demonstrate impaired cerebral vasoreactivity.
- Lower BHI values in pediatric SCD patients suggest a compromised cerebral autoregulation capacity.
- These findings highlight a potential risk factor for cerebrovascular events in children with SCD.
Background:
Impairment of vasodilatory capacity reflecting reduced cerebrovascular reserve was previously shown in adults with sickle cell disease (SCD) and might play a role in the pathophysiology of stroke in such patients. We examined the hypothesis that children with SCD would also have a higher frequency of impaired cerebral vasoreactivity when compared with healthy age- and gender-matched controls.
Methods:
Patients were recruited from our hematology outpatient clinic. All SCD patients aged 10-18 years without a history of symptomatic stroke as well as age- and gender-matched healthy children were evaluated with transcranial Doppler (TCD) ultrasonography, with breath-holding maneuver. Breath-holding index (BHI) was calculated by dividing the percentage increase in mean flow velocity occurring during breath holding by the length of time subjects hold their breath after a normal inspiration. BHI was considered abnormal if less than .69.
Results:
TCD was performed in 42 patients (mean age 12.7 ± 2.2 years) and 20 controls (mean age 13.90 ± 3.04 years). Blood flow velocities were higher in patients with SCD than in controls in all arteries evaluated (P < .001). BHI values in patients with SCD were significantly lower than in control subjects (1.27 ± .65 versus 1.74 ± .15, P = .013 on the left and 1.16 ± .45 versus 1.61 ± .11, P = .002 on the right). BHI was abnormal in 19% of the patients and in none of the controls, P = .036.
Conclusions:
Children with SCD may have impaired cerebral vasoreactivity, with low BHI values suggesting a reduced autoregulation capacity.
Related Concept Videos
Doppler Effect - I
Doppler Effect - II
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
EPS and iPS Cells in Disease Research
Drug Dosing: Infants and Children
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

